Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Abbott Laboratories    ABT   US0028241000

SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Abbott Laboratories : Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Sales38 85139 87421 84822 48423 60824 991
Operating income (EBITDA)11 21612 6164 9745 4265 8536 387
Operating profit (EBIT)9 0109 8334 0464 1354 5674 765
Pre-Tax Profit (EBT)5 1996 2632 521---
Net income4 7295 9632 5762 2383 1073 376
EPS ( $)3,013,721,621,392,082,32
Dividend per Share ( $)1,881,670,640,861,041,20
Yield4,38%3,89%1,49%2,01%2,42%2,81%
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Finances - Leverage
Abbott Laboratories : Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201120122013201420152016
Debt8 6029 6743 0862 9512 5412 447
Finance------
Operating income (EBITDA)11 21612 6164 9745 4265 8536 387
Leverage
(Debt/EBITDA)
0,77x0,77x0,62x0,54x0,43x0,38x
Capital Expenditure1 4921 7951 1451 1051 0831 275
Book Value Per Share (BVPS)15,6 $17,0 $16,3 $16,6 $18,0 $19,6 $
Cash Flow per Share5,72 $5,85 $2,11 $2,87 $2,94 $3,50 $
Announcement Date01/25/2012
12:46pm
01/23/2013
12:47pm
01/22/2014
12:44pm
---
Balance Sheet Analysis
Abbott Laboratories : Balance Sheet Analysis
Assessed data source :
© 2014 Thomson Reuters
Advertisement
Financial Ratios

Size 2014e 2015e
Capitalization 64 418 M$ -
Entreprise Value (EV) 67 369 M$ 66 959 M$
Valuation 2014e 2015e
PER (Price / EPS) 30,8x 20,6x
Capitalization / Revenue 2,87x 2,73x
EV / Revenue 3,00x 2,84x
EV / EBITDA 12,4x 11,4x
Yield (DPS / Price) 2,01% 2,42%
Profitability 2014e 2015e
Operating Margin (EBIT / Sales) 18,4% 19,3%
operating Leverage (Delta EBIT / Delta Sales) 0,75x 2,09x
Net Margin (Net Profit / Revenue) 9,95% 13,2%
ROA (Net Profit / Asset) 7,75% 7,35%
ROE (Net Profit / Equities) 13,4% 13,2%
Rate of Dividend 61,9% 50,1%
Balance Sheet Analysis 2014e 2015e
CAPEX / Sales   4,91% 4,59%
Cash Flow / Sales (Taux d'autofinancement) 19,1% 18,7%
Capital Intensity (Assets / Sales) 1,28x 1,79x
Financial Leverage (Net Debt / EBITDA) 0,54x 0,43x
Price Earning Ratio
Abbott Laboratories : Price Earning Ratio
EPS & Dividend
Abbott Laboratories : EPS Dividend
Dynamic quotes  
ON
| OFF